GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Active Biotech AB publ ACTI.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

3.45

-4.17%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−SEK 37.3m

FY2016FY2025

Free cash flow

−SEK 64.8m

FY2016FY2025

Shareholders' equity

SEK 55.6m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue————SEK 6.2mSEK 6.7mSEK 8.4mSEK 20.1mSEK 20.2mSEK 19.0m
Research and developmentSEK 25.2mSEK 26.7mSEK 32.5mSEK 42.8mSEK 34.5mSEK 25.5mSEK 28.5mSEK 39.3mSEK 49.4mSEK 58.2m
Operating income−SEK 37.6m−SEK 39.8m−SEK 46.5m−SEK 58.2m−SEK 49.8m−SEK 32.3m−SEK 32.2m−SEK 29.9m−SEK 102.8m−SEK 54.7m
Net income−SEK 37.3m−SEK 39.4m−SEK 45.8m−SEK 58.7m−SEK 49.9m−SEK 32.1m−SEK 36.1m−SEK 36.9m−SEK 108.8m−SEK 59.6m
Diluted earnings per share-0.03-0.07-0.16-0.20-0.20-0.19-0.21-0.21-0.71-0.41

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 70.2mSEK 43.2mSEK 44.0mSEK 51.0mSEK 56.8mSEK 32.2mSEK 67.0mSEK 302.4mSEK 303.8mSEK 412.9m
Cash and short-term investmentsSEK 65.1mSEK 27.4mSEK 36.2mSEK 41.8mSEK 53.1mSEK 26.2mSEK 59.7mSEK 25.6mSEK 25.2mSEK 77.7m
Total liabilitiesSEK 14.6mSEK 11.1mSEK 13.4mSEK 16.5mSEK 10.1mSEK 10.0mSEK 13.2mSEK 214.5mSEK 226.1mSEK 230.3m
DebtSEK 1.7mSEK 3.2mSEK 4.5mSEK 6.0mSEK 986,000SEK 2.0mSEK 3.3mSEK 204.3mSEK 210.4mSEK 216.3m
Shareholders' equitySEK 55.6mSEK 32.1mSEK 30.7mSEK 34.5mSEK 46.7mSEK 22.1mSEK 53.8mSEK 87.9mSEK 77.7mSEK 182.6m
Shares outstanding1,347m596m285m295m253m173m173m173m153m145m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 32.4m−SEK 40.4m−SEK 45.7m−SEK 54.9m−SEK 46.2m−SEK 32.2m−SEK 35.8m−SEK 40.6m−SEK 46.4m−SEK 73.2m
Capital spending−SEK 32.4m——−SEK 245,000——————
Free cash flow−SEK 64.8m−SEK 40.4m−SEK 45.7m−SEK 55.1m−SEK 46.2m−SEK 32.2m−SEK 35.8m−SEK 40.6m−SEK 46.4m−SEK 73.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Operating income−SEK 10.2m−SEK 8.6m−SEK 9.1m−SEK 6.4m−SEK 11.3m−SEK 11.2m−SEK 10.3m−SEK 8.1m
Net income−SEK 10.1m−SEK 8.4m−SEK 9.1m−SEK 6.0m−SEK 11.2m−SEK 11.0m−SEK 10.2m−SEK 8.0m
Diluted earnings per share-0.38-0.32-0.01-0.00-0.01-0.01-0.02-0.01
Cash from operations−SEK 9.0m−SEK 8.0m−SEK 7.0m−SEK 7.0m−SEK 8.0m−SEK 9.0m−SEK 11.0m−SEK 7.0m
Capital spending——−SEK 7.0m—————
Free cash flow——−SEK 14.0m—————
Total assetsSEK 47.9mSEK 58.2mSEK 70.2mSEK 17.0mSEK 22.7mSEK 33.2mSEK 43.2mSEK 14.9m
Cash and short-term investmentsSEK 43.9mSEK 53.3mSEK 65.1mSEK 9.1mSEK 16.8mSEK 26.2mSEK 27.4mSEK 6.2m
Debt——SEK 100,000SEK 400,000SEK 800,000SEK 1.1mSEK 3.2mSEK 1.9m
Shareholders' equitySEK 37.2mSEK 47.2mSEK 55.6mSEK 4.5mSEK 10.5mSEK 21.7mSEK 32.1mSEK 1.4m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-13.6%3.1%-14.4%
Net income-14.0%3.0%-15.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-166.2-78.0-33.9-51.8-65.9-104.8-93.3-121.8-10.1-17.2
Price to sales——————399.2224.054.253.7

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 17 Apr 1998.

FY1998FY1997
Paid in the year0.0280.028
  • 1-to-1 reverse split · 19 Dec 2003
  • 1.425-for-1 split · 11 Apr 2003
  • 10-to-1 reverse split · 6 Jun 1995

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.